CA2011704A1 - Methode et reactifs pour le diagnostic de l'endometriose - Google Patents

Methode et reactifs pour le diagnostic de l'endometriose

Info

Publication number: CA2011704A1
Authority: CA; Canada
Prior art keywords: endometriosis; antibody; antigen; sample; antibodies
Prior art date: 1989-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2011704

Other languages

English (en)

Inventor

Nelson N.H. Teng

Subba Rao Gunupudi

Diane Feingersh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Adeza Biomedical Corp

Original Assignee

Adeza Biomedical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-07

Filing date

1990-03-07

Publication date

1990-09-07

1990-03-07 Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp

1990-09-07 Publication of CA2011704A1 publication Critical patent/CA2011704A1/fr

Status Abandoned legal-status Critical Current

Links

201000009273 Endometriosis Diseases 0.000 title claims abstract description 212
238000000034 method Methods 0.000 title claims abstract description 129
239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 41
238000003745 diagnosis Methods 0.000 title description 6
239000000427 antigen Substances 0.000 claims abstract description 161
102000036639 antigens Human genes 0.000 claims abstract description 159
108091007433 antigens Proteins 0.000 claims abstract description 159
238000009739 binding Methods 0.000 claims abstract description 70
230000027455 binding Effects 0.000 claims abstract description 66
230000003302 anti-idiotype Effects 0.000 claims abstract description 38
238000003018 immunoassay Methods 0.000 claims abstract description 30
210000002966 serum Anatomy 0.000 claims abstract description 22
238000002372 labelling Methods 0.000 claims description 14
241000282414 Homo sapiens Species 0.000 claims description 11
210000004369 blood Anatomy 0.000 claims description 10
239000008280 blood Substances 0.000 claims description 10
210000001124 body fluid Anatomy 0.000 claims description 8
239000010839 body fluid Substances 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 7
239000000523 sample Substances 0.000 abstract description 48
239000012530 fluid Substances 0.000 abstract description 6
239000013610 patient sample Substances 0.000 abstract 1
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 50
210000001519 tissue Anatomy 0.000 description 33
102000004190 Enzymes Human genes 0.000 description 32
108090000790 Enzymes Proteins 0.000 description 32
229960002685 biotin Drugs 0.000 description 32
239000011616 biotin Substances 0.000 description 32
229940088598 enzyme Drugs 0.000 description 32
239000000243 solution Substances 0.000 description 32
210000004027 cell Anatomy 0.000 description 29
235000018102 proteins Nutrition 0.000 description 26
102000004169 proteins and genes Human genes 0.000 description 26
108090000623 proteins and genes Proteins 0.000 description 26
235000020958 biotin Nutrition 0.000 description 25
-1 chromophores Substances 0.000 description 20
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
239000008055 phosphate buffer solution Substances 0.000 description 19
239000000126 substance Substances 0.000 description 16
239000000758 substrate Substances 0.000 description 14
239000000872 buffer Substances 0.000 description 13
210000004408 hybridoma Anatomy 0.000 description 13
108091003079 Bovine Serum Albumin Proteins 0.000 description 12
101150052914 lolA gene Proteins 0.000 description 12
239000002609 medium Substances 0.000 description 11
108090001008 Avidin Proteins 0.000 description 10
BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 10
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
238000003556 assay Methods 0.000 description 10
230000000694 effects Effects 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
238000010186 staining Methods 0.000 description 10
229910019142 PO4 Inorganic materials 0.000 description 9
229920001213 Polysorbate 20 Polymers 0.000 description 9
238000001042 affinity chromatography Methods 0.000 description 9
229940098773 bovine serum albumin Drugs 0.000 description 9
230000008878 coupling Effects 0.000 description 9
238000010168 coupling process Methods 0.000 description 9
238000005859 coupling reaction Methods 0.000 description 9
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 9
239000010452 phosphate Substances 0.000 description 9
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
108010001336 Horseradish Peroxidase Proteins 0.000 description 8
239000012491 analyte Substances 0.000 description 8
239000011248 coating agent Substances 0.000 description 8
238000000576 coating method Methods 0.000 description 8
238000011534 incubation Methods 0.000 description 8
239000000463 material Substances 0.000 description 8
241000699670 Mus sp. Species 0.000 description 7
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
239000000284 extract Substances 0.000 description 7
239000012528 membrane Substances 0.000 description 7
239000012071 phase Substances 0.000 description 7
229910021420 polycrystalline silicon Inorganic materials 0.000 description 7
229920005591 polysilicon Polymers 0.000 description 7
239000006228 supernatant Substances 0.000 description 7
235000012431 wafers Nutrition 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
238000002965 ELISA Methods 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 6
206010035226 Plasma cell myeloma Diseases 0.000 description 6
239000008366 buffered solution Substances 0.000 description 6
230000002357 endometrial effect Effects 0.000 description 6
230000003053 immunization Effects 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
201000000050 myeloid neoplasm Diseases 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 6
238000012360 testing method Methods 0.000 description 6
108020004774 Alkaline Phosphatase Proteins 0.000 description 5
102000002260 Alkaline Phosphatase Human genes 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
108060003951 Immunoglobulin Proteins 0.000 description 5
206010033128 Ovarian cancer Diseases 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
230000005540 biological transmission Effects 0.000 description 5
239000002981 blocking agent Substances 0.000 description 5
238000013461 design Methods 0.000 description 5
238000002405 diagnostic procedure Methods 0.000 description 5
210000002919 epithelial cell Anatomy 0.000 description 5
239000012634 fragment Substances 0.000 description 5
102000018358 immunoglobulin Human genes 0.000 description 5
229910052751 metal Inorganic materials 0.000 description 5
239000002184 metal Substances 0.000 description 5
229910052757 nitrogen Inorganic materials 0.000 description 5
239000013641 positive control Substances 0.000 description 5
230000005855 radiation Effects 0.000 description 5
239000003656 tris buffered saline Substances 0.000 description 5
238000000108 ultra-filtration Methods 0.000 description 5
241000283707 Capra Species 0.000 description 4
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
239000004677 Nylon Substances 0.000 description 4
239000004793 Polystyrene Substances 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
239000007853 buffer solution Substances 0.000 description 4
239000012228 culture supernatant Substances 0.000 description 4
239000003085 diluting agent Substances 0.000 description 4
230000004927 fusion Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
239000003550 marker Substances 0.000 description 4
210000004379 membrane Anatomy 0.000 description 4
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
239000002736 nonionic surfactant Substances 0.000 description 4
229920001778 nylon Polymers 0.000 description 4
239000000049 pigment Substances 0.000 description 4
229920000056 polyoxyethylene ether Polymers 0.000 description 4
229920002223 polystyrene Polymers 0.000 description 4
238000000159 protein binding assay Methods 0.000 description 4
230000002285 radioactive effect Effects 0.000 description 4
238000012216 screening Methods 0.000 description 4
238000001179 sorption measurement Methods 0.000 description 4
239000000725 suspension Substances 0.000 description 4
229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 3
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
206010003445 Ascites Diseases 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
208000026310 Breast neoplasm Diseases 0.000 description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
206010014733 Endometrial cancer Diseases 0.000 description 3
206010014759 Endometrial neoplasm Diseases 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
239000004698 Polyethylene Substances 0.000 description 3
241000700159 Rattus Species 0.000 description 3
229920005654 Sephadex Polymers 0.000 description 3
239000012507 Sephadex™ Substances 0.000 description 3
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
239000013504 Triton X-100 Substances 0.000 description 3
229920004890 Triton X-100 Polymers 0.000 description 3
SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 3
235000021120 animal protein Nutrition 0.000 description 3
230000021615 conjugation Effects 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
201000003914 endometrial carcinoma Diseases 0.000 description 3
235000013861 fat-free Nutrition 0.000 description 3
239000012847 fine chemical Substances 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000002083 iodinating effect Effects 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
239000013642 negative control Substances 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
210000002381 plasma Anatomy 0.000 description 3
229920000573 polyethylene Polymers 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
201000009030 Carcinoma Diseases 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
208000005171 Dysmenorrhea Diseases 0.000 description 2
206010013935 Dysmenorrhoea Diseases 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
229920001214 Polysorbate 60 Polymers 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
210000000683 abdominal cavity Anatomy 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
201000008275 breast carcinoma Diseases 0.000 description 2
239000007975 buffered saline Substances 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
239000005018 casein Substances 0.000 description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
235000021240 caseins Nutrition 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000004590 computer program Methods 0.000 description 2
229920001577 copolymer Polymers 0.000 description 2
239000007822 coupling agent Substances 0.000 description 2
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003599 detergent Substances 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
238000010828 elution Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
238000002649 immunization Methods 0.000 description 2
238000010166 immunofluorescence Methods 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
230000036512 infertility Effects 0.000 description 2
208000000509 infertility Diseases 0.000 description 2
231100000535 infertility Toxicity 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000010410 layer Substances 0.000 description 2
235000018977 lysine Nutrition 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000004264 monolayer culture Methods 0.000 description 2
229940126619 mouse monoclonal antibody Drugs 0.000 description 2
230000002611 ovarian Effects 0.000 description 2
229960003330 pentetic acid Drugs 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
229920001308 poly(aminoacid) Polymers 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
239000000047 product Substances 0.000 description 2
239000000941 radioactive substance Substances 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
239000004065 semiconductor Substances 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000012679 serum free medium Substances 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
239000010703 silicon Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
239000003104 tissue culture media Substances 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 1
JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
JTNGEYANGCBZLK-UHFFFAOYSA-N 1h-indol-3-yl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CNC2=C1 JTNGEYANGCBZLK-UHFFFAOYSA-N 0.000 description 1
IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
229960005508 8-azaguanine Drugs 0.000 description 1
238000013296 A/J mouse Methods 0.000 description 1
101150034533 ATIC gene Proteins 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
108010052875 Adenine deaminase Proteins 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
108090000531 Amidohydrolases Proteins 0.000 description 1
102000004092 Amidohydrolases Human genes 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000004452 Arginase Human genes 0.000 description 1
108700024123 Arginases Proteins 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
102000016938 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
241000237074 Centris Species 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
108020005199 Dehydrogenases Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
229930189936 Glyoxalase Natural products 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
102000005548 Hexokinase Human genes 0.000 description 1
108700040460 Hexokinases Proteins 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
108010093096 Immobilized Enzymes Proteins 0.000 description 1
102000005385 Intramolecular Transferases Human genes 0.000 description 1
108010031311 Intramolecular Transferases Proteins 0.000 description 1
241000408495 Iton Species 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000711408 Murine respirovirus Species 0.000 description 1
101100399552 Neisseria meningitidis serogroup B (strain MC58) lolD gene Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
239000007990 PIPES buffer Substances 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
241001494479 Pecora Species 0.000 description 1
208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
208000000450 Pelvic Pain Diseases 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
102000009097 Phosphorylases Human genes 0.000 description 1
108010073135 Phosphorylases Proteins 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
229920001328 Polyvinylidene chloride Polymers 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
JQYMGXZJTCOARG-UHFFFAOYSA-N Reactive blue 2 Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC(S(O)(=O)=O)=C1 JQYMGXZJTCOARG-UHFFFAOYSA-N 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
229910052581 Si3N4 Inorganic materials 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
102000003425 Tyrosinase Human genes 0.000 description 1
108060008724 Tyrosinase Proteins 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000001252 acrylic acid derivatives Chemical class 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
125000005210 alkyl ammonium group Chemical group 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
150000001615 biotins Chemical class 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
229920005549 butyl rubber Polymers 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
239000013522 chelant Substances 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000004020 conductor Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
229910021419 crystalline silicon Inorganic materials 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000005684 electric field Effects 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
210000004696 endometrium Anatomy 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
208000037828 epithelial carcinoma Diseases 0.000 description 1
230000005284 excitation Effects 0.000 description 1
238000002270 exclusion chromatography Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000000834 fixative Substances 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000011888 foil Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
102000054766 genetic haplotypes Human genes 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229920000578 graft copolymer Polymers 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
230000002962 histologic effect Effects 0.000 description 1
230000003118 histopathologic effect Effects 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
229940124452 immunizing agent Drugs 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
229920000592 inorganic polymer Polymers 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000012948 isocyanate Substances 0.000 description 1
IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
150000002513 isocyanates Chemical class 0.000 description 1
150000002540 isothiocyanates Chemical group 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
238000002357 laparoscopic surgery Methods 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
101150114977 lolB gene Proteins 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
125000001288 lysyl group Chemical group 0.000 description 1
229940018564 m-phenylenediamine Drugs 0.000 description 1
239000000696 magnetic material Substances 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000005906 menstruation Effects 0.000 description 1
150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
229910052752 metalloid Inorganic materials 0.000 description 1
150000002738 metalloids Chemical class 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
235000006109 methionine Nutrition 0.000 description 1
230000037230 mobility Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
150000005002 naphthylamines Chemical class 0.000 description 1
231100001160 nonlethal Toxicity 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
210000003101 oviduct Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
210000003516 pericardium Anatomy 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
229920002120 photoresistant polymer Polymers 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
230000019612 pigmentation Effects 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
210000004224 pleura Anatomy 0.000 description 1
229920002285 poly(styrene-co-acrylonitrile) Polymers 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001748 polybutylene Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
229920006324 polyoxymethylene Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
229920002620 polyvinyl fluoride Polymers 0.000 description 1
239000005033 polyvinylidene chloride Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
235000013930 proline Nutrition 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012264 purified product Substances 0.000 description 1
NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
239000002964 rayon Substances 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
229940043267 rhodamine b Drugs 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229920000260 silastic Polymers 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
150000004760 silicates Chemical class 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
238000002764 solid phase assay Methods 0.000 description 1
241000894007 species Species 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
210000004988 splenocyte Anatomy 0.000 description 1
238000007447 staining method Methods 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000001629 suppression Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000002023 wood Substances 0.000 description 1
239000001018 xanthene dye Substances 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

CA 2011704 1989-03-07 1990-03-07 Methode et reactifs pour le diagnostic de l'endometriose Abandoned CA2011704A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32002389A	1989-03-07	1989-03-07
US07/320,023		1989-03-07

Publications (1)

Publication Number	Publication Date
CA2011704A1 true CA2011704A1 (fr)	1990-09-07

Family

ID=23244551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2011704 Abandoned CA2011704A1 (fr)	1989-03-07	1990-03-07	Methode et reactifs pour le diagnostic de l'endometriose

Country Status (1)

Country	Link
CA (1)	CA2011704A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618680A (en) *	1994-12-28	1997-04-08	Institut De Medecine De La Reproduction De Montreal	Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
US6376201B2 (en)	1994-12-28	2002-04-23	Procrea Biosciences Inc.	Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis

1990
- 1990-03-07 CA CA 2011704 patent/CA2011704A1/fr not_active Abandoned

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618680A (en) *	1994-12-28	1997-04-08	Institut De Medecine De La Reproduction De Montreal	Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
US6376201B2 (en)	1994-12-28	2002-04-23	Procrea Biosciences Inc.	Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis

Legal Events

Date	Code	Title	Description
1990-10-03	EEER	Examination request
1993-09-07	FZDE	Dead

Publication	Publication Date	Title
CA1338899C (fr)	1997-02-11	Immuno-essai et reactifs pour eclampsie et hypertension dues a la grossesse
US5202234A (en)	1993-04-13	Myocardial infarction immunoassay
Nishio et al.	1997	Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis
US4812397A (en)	1989-03-14	MAB-anti-DNA related to nephritis
US5382515A (en)	1995-01-17	Creative kinase-MB immunoassay for myocardial infarction and reagents
CA1337394C (fr)	1995-10-24	Test a prelevement vaginal et reactifs
US5118611A (en)	1992-06-02	Adenocarcinoma antigen binding methods and reagents
EP0741144B1 (fr)	2002-07-24	Anticorps monoclonal antiannexine-v, procede pour produire cet anticorps, et utilisation de cet anticorps
US5382522A (en)	1995-01-17	Immunoassay for creatine kinase-MB and creatine kinase-BB isoforms and reagents
US5223440A (en)	1993-06-29	Ex vivo product of conception test to determine abortion
JP2567564B2 (ja)	1996-12-25	ヒト非小細胞肺癌に関する抗原
Scully et al.	1988	AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens
EP0387027A2 (fr)	1990-09-12	Méthodes et réactifs pour le diagnostic de l'endométriose
US5185270A (en)	1993-02-09	Fetal fibronectin pregnancy test
AU582731B2 (en)	1989-04-13	Specific cea-family antigens, antibodies specific thereto and their methods of use
EP0267690A1 (fr)	1988-05-18	Titrage d'un immun-complexe
JP2000515854A (ja)	2000-11-28	脳タンパク質ｓ―１００の存在の測定方法
Raynor et al.	1984	Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker
JPH0827286B2 (ja)	1996-03-21	ヒト胎盤由来酸性グルタチオンｓ−トランスフェラ−ゼの測定方法及び試薬キット
CA2281262C (fr)	2010-08-31	Anticorps monoclonal anti-medullasine humaine, processus de production et dosage immunologique utilisant cet anticorps moinoclonal
KR100426029B1 (ko)	2004-07-31	동종 및 이종 단백질에 대한 항체, 그 항체를 이용한 진단 및 치료방법 및 그 항체의 측정방법
JPWO1997008549A1 (ja)	1998-10-20	腎疾患の検知法、診断薬及び診断用キット
WO1991016633A1 (fr)	1991-10-31	Immunoanalyse et reactifs de detection d'hypertension induite pa r une grossesse et d'eclampsie
CA2047298A1 (fr)	1992-01-19	Dosage immunologique utilise pour le diagnostic de l'infarctus du myocarde
JP2558956B2 (ja)	1996-11-27	ヒト・オステオカルシンの免疫学的測定方法、そのための試薬及びキツト、ヒト・オステオカルシンに対する抗体、それを産生するハイブリドーマ及びそれを産生する方法

CA2011704A1 - Methode et reactifs pour le diagnostic de l'endometriose - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=23244551

Family Applications (1)

Country Status (1)

Cited By (2)

Cited By (2)

Similar Documents

Legal Events